Flaxseed Bioactive Compounds and Colorectal Cancer Prevention

被引:48
作者
DeLuca, Jennifer A. A. [1 ]
Garcia-Villatoro, Erika L. [1 ]
Allred, Clinton D. [1 ]
机构
[1] Texas A&M Univ, Dept Nutr & Food Sci, 2253 TAMU,373 Olsen Blvd, College Stn, TX 77843 USA
关键词
Colorectal cancer; Flaxseed; Fiber; Alpha-linolenic acid; Lignan; Dietary bioactive compounds; ALPHA-LINOLENIC ACID; POLYUNSATURATED FATTY-ACIDS; COLON-CANCER; DIETARY FLAXSEED; IN-VITRO; LIGNANS; FIBER; ENTEROLIGNANS; MECHANISMS; PLASMA;
D O I
10.1007/s11912-018-0704-z
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Flaxseed and its bioactive components have been associated with a decreased risk of colorectal cancer incidence and progression. This review aims to summarize recent research regarding the role of flaxseed and each of its major dietary bioactive components in reducing colorectal cancer. In both human and animal model experiments, flaxseed consumption had beneficial effects on colon physiology associated with reduction in colorectal cancer risk or occurrence. Considered separately, each of flaxseed's major bioactive components, including fiber, alpha-linolenic acid, lignans, and other phytochemicals, is also associated with decreased risk of colonic neoplasms and regulation of cell growth through several potential mechanisms. Collectively, experimental data suggests that consumption of flaxseed and/or its bioactive components may reduce colorectal cancer risk by a variety of mechanisms. Future studies should focus on the mechanisms by which whole flaxseed can prevent colorectal cancer.
引用
收藏
页数:8
相关论文
共 63 条
[1]   Familial adenomatous polyposis patients have high levels of arachidonic acid and docosahexaenoic acid and low levels of linoleic acid and α-linolenic acid in serum phospholipids [J].
Almendingen, Kari ;
Hostmark, Arne T. ;
Fausa, Olav ;
Mosdol, Annhild ;
Aabakken, Lars ;
Vatn, Morten H. .
INTERNATIONAL JOURNAL OF CANCER, 2007, 120 (03) :632-637
[2]  
Alshafe MM, 2015, RES J PHARM BIOL CHE, V6, P1944
[3]  
[Anonymous], 2007, FLAX HLTH NUTR PRIME
[4]  
[Anonymous], CHEMOPROTECTIVE EFFE
[5]  
[Anonymous], GRAS NOT 000280 WHOL
[6]  
[Anonymous], 2017, KEY STAT COL CANC
[7]  
[Anonymous], 2012, Journal of Nutrition & Food Sciences
[8]  
[Anonymous], AM J CLIN NUTR
[9]  
[Anonymous], COL CANC RISK FACT
[10]   Abnormalities in plasma and red blood cell fatty acid profiles of patients with colorectal cancer [J].
Baró, L ;
Hermoso, JC ;
Núñez, MC ;
Jiménez-Rios, JA ;
Gil, A .
BRITISH JOURNAL OF CANCER, 1998, 77 (11) :1978-1983